Abel Hall LLC
RVMD icon

Abel Hall LLC’s Revolution Medicines RVMD Stock Holding History

Abel Hall LLC’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.1M Sell
5,381
-13
-0.2% -$2.58K 0.2% 66
2026
Q2 		$1.01M Sell
5,394
-448
-8% -$65.4K 0.17% 82
2026
Q1 		$568K Buy
5,842
+334
+6% +$33.7K 0.12% 156
2025
Q4 		$439K Buy
+5,508
New +$361K 0.1% 209

Other funds holding RVMD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Loftus Peak Pty Ltd
Loftus Peak Pty Ltd Sydney, Australia $781M AUM
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Abel Hall LLC's RVMD Position: Q3 2026 in Review

Abel Hall LLC reduced its Revolution Medicines (RVMD) stake by 0.24% in Q3 2026, selling an estimated $2.58K and leaving 5,381 shares worth $1.1M. The position accounts for 0.2% of the portfolio, ranked #66.

Abel Hall LLC first reported a position in RVMD in Q4 2025 and has held it in 4 quarters since. 181 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Abel Hall LLC held 5,381 shares of Revolution Medicines worth $1.1M as of Q3 2026.
  • Abel Hall LLC sold 13 Revolution Medicines shares in Q3 2026, an estimated $2.58K.
  • Revolution Medicines made up 0.2% of Abel Hall LLC's portfolio in Q3 2026, its #66 holding.
  • Abel Hall LLC first reported a position in Revolution Medicines in Q4 2025 and has held it in 4 quarters since.
  • 181 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.